Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.

Serena BugattiLudovico De StefanoSilvia BalduzziMaria Immacolata GrecoTerenzj LuvaroIrene CassanitiLaura BoglioloIolanda MazzucchelliBernardo D'OnofrioMichele di LerniaEleonora MauricDaniele LilleriFausto BaldantiAntonio ManzoCarlomaurizio Montecucco

Published in: Annals of the rheumatic diseases (2021)

Keyphrases

coronavirus disease
sars cov
rheumatoid arthritis
high dose
oxidative stress
binding protein
low dose
mesenchymal stem cells
replacement therapy